These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 23726465)

  • 1. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of different carbapenemase genes among carbapenem-resistant
    Wang TH; Leu YS; Wang NY; Liu CP; Yan TR
    Antimicrob Resist Infect Control; 2018; 7():123. PubMed ID: 30338061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
    J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
    Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
    Lu PL; Doumith M; Livermore DM; Chen TP; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):641-7. PubMed ID: 19182237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
    Rieber H; Frontzek A; Pfeifer Y
    Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
    Ahmed SS; Alp E; Ulu-Kilic A; Dinc G; Aktas Z; Ada B; Bagirova F; Baran I; Ersoy Y; Esen S; Guven TG; Hopman J; Hosoglu S; Koksal F; Parlak E; Yalcin AN; Yilmaz G; Voss A; Melchers W
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1463-8. PubMed ID: 27259712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
    Gogou V; Pournaras S; Giannouli M; Voulgari E; Piperaki ET; Zarrilli R; Tsakris A
    J Antimicrob Chemother; 2011 Dec; 66(12):2767-72. PubMed ID: 21933784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).
    Chagas TP; Carvalho KR; de Oliveira Santos IC; Carvalho-Assef AP; Asensi MD
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):468-72. PubMed ID: 24880823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
    Ruan Z; Chen Y; Jiang Y; Zhou H; Zhou Z; Fu Y; Wang H; Wang Y; Yu Y
    Int J Antimicrob Agents; 2013 Oct; 42(4):322-8. PubMed ID: 23988720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the genetic elements bla oxa and IS Aba 1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting.
    Kobs VC; Ferreira JA; Bobrowicz TA; Ferreira LE; Deglmann RC; Westphal GA; França PH
    Rev Soc Bras Med Trop; 2016; 49(4):433-40. PubMed ID: 27598629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
    Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
    J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.